ZA9811349B - Statin-lp (a) inhibitor combinations - Google Patents
Statin-lp (a) inhibitor combinationsInfo
- Publication number
- ZA9811349B ZA9811349B ZA9811349A ZA9811349A ZA9811349B ZA 9811349 B ZA9811349 B ZA 9811349B ZA 9811349 A ZA9811349 A ZA 9811349A ZA 9811349 A ZA9811349 A ZA 9811349A ZA 9811349 B ZA9811349 B ZA 9811349B
- Authority
- ZA
- South Africa
- Prior art keywords
- statin
- inhibitor combinations
- inhibitor
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6943297P | 1997-12-12 | 1997-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9811349B true ZA9811349B (en) | 1999-06-14 |
Family
ID=22088939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9811349A ZA9811349B (en) | 1997-12-12 | 1998-12-10 | Statin-lp (a) inhibitor combinations |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1037623A1 (en) |
JP (1) | JP2003524582A (en) |
KR (1) | KR20010033017A (en) |
AU (2) | AU1306099A (en) |
BR (1) | BR9813539A (en) |
CA (1) | CA2299397A1 (en) |
HU (1) | HUP0100349A3 (en) |
IL (1) | IL134364A0 (en) |
IS (1) | IS5385A (en) |
NO (1) | NO20002965D0 (en) |
NZ (1) | NZ502874A (en) |
PL (1) | PL343851A1 (en) |
WO (1) | WO1999030706A1 (en) |
ZA (1) | ZA9811349B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1629849T4 (en) | 1997-01-07 | 2017-12-04 | Amylin Pharmaceuticals Llc | Pharmaceutical compositions comprising exedins and agonists thereof |
EP1076091A1 (en) * | 1999-08-09 | 2001-02-14 | Universite Catholique De Louvain | Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
DE60105547T3 (en) * | 2000-01-10 | 2014-12-31 | Amylin Pharmaceuticals, Llc | USE OF EXENDINES AND THEIR AGONISTS FOR THE TREATMENT OF HYPERTRIGLIC CERIDEMIA |
AU2001232245A1 (en) * | 2000-02-10 | 2001-08-20 | Takeda Chemical Industries Ltd. | Tnf- alpha inhibitors |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2016467A1 (en) * | 1989-06-05 | 1990-12-05 | Martin Eisman | Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor |
AU3473193A (en) * | 1992-01-17 | 1993-08-03 | Procter & Gamble Company, The | Treatment for atherosclerosis |
WO1993016690A1 (en) * | 1992-02-25 | 1993-09-02 | Warner-Lambert Company | Cytoprotective compositions containing pyruvate and antioxidants |
US5720963A (en) * | 1994-08-26 | 1998-02-24 | Mary Kay Inc. | Barrier disruption treatments for structurally deteriorated skin |
US5648387A (en) * | 1995-03-24 | 1997-07-15 | Warner-Lambert Company | Carboxyalkylethers, formulations, and treatment of vascular diseases |
EP0738510A3 (en) * | 1995-04-20 | 2005-12-21 | L'oreal | Use of a HMG-CoA reductase inhibitor as an anti-ageing agent and as an anti-acne agent. Composition comprising at least one HMG-CoA reductase inhibitor and at least one active substance with scaling properties. |
WO1997038694A1 (en) * | 1996-04-17 | 1997-10-23 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardiovascular disease |
NZ503982A (en) * | 1997-12-12 | 2002-03-28 | Warner Lambert Co | Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus |
-
1998
- 1998-11-04 NZ NZ502874A patent/NZ502874A/en unknown
- 1998-11-04 EP EP98956562A patent/EP1037623A1/en not_active Ceased
- 1998-11-04 WO PCT/US1998/023480 patent/WO1999030706A1/en not_active Application Discontinuation
- 1998-11-04 JP JP2000538689A patent/JP2003524582A/en active Pending
- 1998-11-04 HU HU0100349A patent/HUP0100349A3/en unknown
- 1998-11-04 CA CA002299397A patent/CA2299397A1/en not_active Abandoned
- 1998-11-04 PL PL98343851A patent/PL343851A1/en unknown
- 1998-11-04 IL IL13436498A patent/IL134364A0/en unknown
- 1998-11-04 BR BR9813539-2A patent/BR9813539A/en not_active Application Discontinuation
- 1998-11-04 KR KR1020007006370A patent/KR20010033017A/en not_active Application Discontinuation
- 1998-11-04 AU AU13060/99A patent/AU1306099A/en not_active Abandoned
- 1998-12-10 ZA ZA9811349A patent/ZA9811349B/en unknown
-
2000
- 2000-02-25 IS IS5385A patent/IS5385A/en unknown
- 2000-06-09 NO NO20002965A patent/NO20002965D0/en not_active Application Discontinuation
-
2003
- 2003-08-29 AU AU2003244047A patent/AU2003244047A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IS5385A (en) | 2000-02-25 |
CA2299397A1 (en) | 1999-06-24 |
BR9813539A (en) | 2000-10-10 |
NZ502874A (en) | 2004-03-26 |
NO20002965L (en) | 2000-06-09 |
HUP0100349A3 (en) | 2002-02-28 |
PL343851A1 (en) | 2001-09-10 |
AU2003244047A1 (en) | 2003-09-25 |
HUP0100349A2 (en) | 2001-07-30 |
NO20002965D0 (en) | 2000-06-09 |
WO1999030706A1 (en) | 1999-06-24 |
IL134364A0 (en) | 2001-04-30 |
EP1037623A1 (en) | 2000-09-27 |
KR20010033017A (en) | 2001-04-25 |
AU1306099A (en) | 1999-07-05 |
JP2003524582A (en) | 2003-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0975273A4 (en) | A pre-operative technique | |
GB2321641B (en) | Sulfamide-metalloprotease inhibitors | |
GB9608062D0 (en) | A Case | |
EG21217A (en) | A metallogene compounds | |
GB9704222D0 (en) | A component | |
ZA9811349B (en) | Statin-lp (a) inhibitor combinations | |
GB2326461B (en) | A tap | |
GB9717959D0 (en) | A holdall | |
AU129623S (en) | A hammer | |
GB9717893D0 (en) | Inhibitor | |
GB9707219D0 (en) | Inhibitor | |
AU132788S (en) | A pareo | |
AU133234S (en) | A teapot-container | |
IL120253A0 (en) | A screw - wrench | |
GB9712190D0 (en) | A book-end | |
AU135496S (en) | A crumpet | |
AU132787S (en) | A pareo | |
GB9715367D0 (en) | A dredgehead | |
GB9721943D0 (en) | A component | |
AU129750S (en) | A case | |
ZA988491B (en) | A time piece | |
AU129626S (en) | A time piece | |
AU129522S (en) | A time piece | |
AU133796S (en) | A board | |
TW334965U (en) | A hand-cart structure (II) |